0001062993-23-022719.txt : 20231218 0001062993-23-022719.hdr.sgml : 20231218 20231218130614 ACCESSION NUMBER: 0001062993-23-022719 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231218 DATE AS OF CHANGE: 20231218 EFFECTIVENESS DATE: 20231218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Proteocyte Diagnostics Inc. CENTRAL INDEX KEY: 0001987946 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-499990 FILM NUMBER: 231492931 BUSINESS ADDRESS: STREET 1: MARS CENTRE, SOUTH TOWER STREET 2: 101 COLLEGE STREET, SUITE 200 CITY: TORONTO STATE: A6 ZIP: M5G 1L7 BUSINESS PHONE: (647) 255-1370 MAIL ADDRESS: STREET 1: MARS CENTRE, SOUTH TOWER STREET 2: 101 COLLEGE STREET, SUITE 200 CITY: TORONTO STATE: A6 ZIP: M5G 1L7 D 1 primary_doc.xml X0708 D LIVE 0001987946 Proteocyte Diagnostics Inc. MARS CENTRE, SOUTH TOWER 101 COLLEGE STREET, SUITE 200 TORONTO A6 ONTARIO, CANADA M5G 1L7 (647) 255-1370 ONTARIO, CANADA None None Corporation true John Jordan MaRS Centre, South Tower 101 College Street, Suite 200 Toronto A6 ONTARIO, CANADA M5G 1L7 Executive Officer Director Steven Arless MaRS Centre, South Tower 101 College Street, Suite 200 Toronto A6 ONTARIO, CANADA M5G 1L7 Director Mark Hammer MaRS Centre, South Tower 101 College Street, Suite 200 Toronto A6 ONTARIO, CANADA M5G 1L7 Executive Officer Anthony Morlandt MaRS Centre, South Tower 101 College Street, Suite 200 Toronto A6 ONTARIO, CANADA M5G 1L7 Director Barrie Renick MaRS Centre, South Tower 101 College Street, Suite 200 Toronto A6 ONTARIO, CANADA M5G 1L7 Director Carlo Sistilli MaRS Centre, South Tower 101 College Street, Suite 200 Toronto A6 ONTARIO, CANADA M5G 1L7 Director Biotechnology Decline to Disclose 06b false 2023-12-04 false true true true Convertible Note (the ?Note?) in the principal amount of C$50,000. The type and class of share that the Note converts into will be determined at a future date (upon a future "qualified financing"). The note carries an interest rate of 8% per annum. false 50000 36925 36925 0 Total Offering Amount represents the principal amount of the Note. Based on Bank of Canada exchange rate reported on December 4, 2023 CAD$1.00:USD$0.7385. false 1 0 0 0 false Proteocyte Diagnostics Inc. /s/ John Jordan John Jordan Chief Financial Officer 2023-12-18